Company Filing History:
4 out of 1,168 
1 out of 1,627 
3 out of 832,761 Years Active: 1990-2003
Title: David Lavie: Innovator in Antiviral Research
Introduction
David Lavie is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of antiviral research, holding a total of 7 patents. His work focuses on developing novel compounds and pharmaceutical compositions aimed at treating viral infections.
Latest Patents
Among his latest patents, Lavie has developed antiviral agents that include novel antiviral compounds. These compounds are mono- or dicarboxylic acid esters of hypericin, where one or both of the methyl groups of hypericin are substituted by carboxylic acid ester groups. The formula COOR, where R is an alkyl chain, is a key component of these compounds. R can be methyl, ethyl, propyl, butyl, 2-methoxyethyl, or 2-(2-methoxyethoxy)ethyl. These compounds can be formulated into pharmaceutical compositions and utilized in various applications known for hypericin. Additionally, he has worked on plant extracts for preparing pharmaceutical compositions for treating hepatitis C and related viruses. These compositions comprise extracts from the plant Hypericum perforatum, along with pharmaceutically acceptable inactive components.
Career Highlights
David Lavie has had a notable career, contributing to significant advancements in antiviral therapies. His work has been recognized in various scientific communities, and he has been instrumental in developing innovative solutions for viral infections.
Collaborations
Throughout his career, Lavie has collaborated with esteemed colleagues, including Michel Revel and Dalia Rotman. These partnerships have further enhanced his research and development efforts in the field of antiviral agents.
Conclusion
David Lavie's contributions to antiviral research and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for new treatments and therapies for viral infections.